Impressions: 633
The US Food and Drug Administration (FDA) has granted accelerated approval to Incyte’s monoclonal antibody Zynyz (retifanlimab) as a treatment for a rare and aggressive type of skin cancer known as Merkel cell carcinoma.A panel of external expe...
Impressions: 1205
Biotech M&As picked up this week as Pfizer announced the acquisition of cancer treatment expert Seagen for US$ 43 billion and Sanofi said it will acquire Provention Bio for US$ 2.9 billion.In approvals, Pfizer’s nasal spray for migraine –...
Impressions: 709
An investigation by the US Center for Disease Control and Prevention (CDC) and Gambian scientists has concluded that contaminated cough and paracetamol syrups imported into Gambia caused the deaths of 70 children due to acute kidney injury. The India...
Impressions: 876
Pfizer is in early-stage talks to acquire cancer-focused biotech Seagen for over US$ 30 billion. A panel of external experts to the US Food and Drug Administration (FDA) has backed both GSK and Pfizer’s respiratory syncytial virus (RSV) vaccine...
Impressions: 839
The US Food and Drug Administration (FDA) saw a flurry of approvals this week. The agency has approved Apellis Pharmaceuticals’ drug Syfovre (pegcetacoplan). This is the first-ever treatment for geographic atrophy, a major cause of blindness gl...
Impressions: 2418
A damning report brought out by Bloomberg has said GSK’s scientists knew for decades about the cancer risks associated with its popular heartburn drug Zantac but the drugmaker chose to keep quiet about them. There was good news on GSK’s J...
Impressions: 645
As 2022 results pour
in and the pandemic recedes, drugmakers who made steep profits through the sale
of Covid-19 products over the last two years have forecast a sharp decline in
sales of their vaccines, therapies and kits this year.The US Food an...
Impressions: 658
Covid-19 products – Comirnaty and Paxlovid – have helped Pfizer cross US$ 100 billion in 2022 sales. With the pandemic receding, the drugmaker expects its turnover to drop 33 percent this year.GSK’s drug — Jesduvroq — ha...
Impressions: 2005
The World Health Organization (WHO) has expanded its probe into cough syrup deaths to four other nations, and has also found support from the FDA in the case.The US Food and Drug Administration (FDA) has rejected Eli Lilly’s bid for an accelera...
Impressions: 1253
Last week, the US Food and Drug Administration (FDA) had flagged problems at manufacturing facilities of Intas and Sun Pharma. This week, three other Indian drugmakers – Lupin, Aurobindo Pharma and Granules India – have received the agenc...